The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, SVB Securities and Piper Sandler acted as joint book running managers for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FULC:
- Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
- Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
- Fulcrum Therapeutics announces $100M common stock offering
- Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Fulcrum reports ‘encouraging’ Phase 1b data for FTX-6058, says Piper Sandler
